
DSIP
DSIP (Delta Sleep-Inducing Peptide)
Also called DSIP, delta sleep-inducing peptide
A 1970s sleep peptide with old, thin evidence
DSIP was found in the 1970s in preclinical sleep research and named after the deep, slow brain waves it seemed to bring on. Fifty years later it is still not clear how it works, or whether it does in people: the small human studies from the 1980s were mixed. It is not an approved medicine.
A nine-amino-acid neuropeptide first isolated in preclinical work for an apparent effect on delta-wave (deep) sleep. Small human studies from the 1980s gave mixed results, and it has not been tested with modern sleep measurement. Its mechanism is still unresolved, and it is not an approved medicine.
- Status
- Not FDA-approved
Early research, mostly in the lab so far
What DSIP has been studied for
The reasons people look it up, roughly in order of how often, and what research exists for each. Interest in a use is not evidence that it works; the evidence is stated under each one.
- Sleep
- The reason people look it up. Small 1980s studies in people with insomnia gave mixed results, and no modern trial has tested it.
- Stress and recovery
- A secondary use, on the basis that it appears to influence stress hormones. Thinly supported.
Mechanism of Action
How DSIP works
DSIP's targets remain unresolved. What the research describes:
- Delta-wave sleep. Early preclinical work reported more slow-wave (deep) sleep; human results were mixed.
- Stress hormones. Some studies report effects on stress-hormone rhythms.
- No identified receptor. No specific receptor for DSIP has been confirmed, which is part of why its mechanism is still debated.
DSIP side effects: what studies reported
Very little documented, which may reflect a mild compound or one that does little.
Reported outside trials
- Grogginess the next morning
- Injection-site redness
- Vivid dreams
- Headache
Worth keeping an eye on
- Reported effects vary widely between people, and many report none
Source: Early human work from the 1980s and reports outside trials since. This is a summary of published findings, not a complete safety profile and not medical advice. Questions about DSIP belong with a licensed clinician who knows your history.
Your Genetics & DSIP
The genes involved in how DSIP works
DSIP works through the receptors these genes build, and the genes vary from person to person. Researchers have linked some of that variation to differences in how people respond. A DNA report tells you which versions you carry.
ADA · ••
The rare A allele of this adenosine deaminase variant has been associated with deeper, more intense slow-wave sleep in human sleep studies. That is a sleep trait, not a response to DSIP; no study has tested DSIP by genotype.
PER3 · ••
The PER3 repeat has been associated with chronotype (morning or evening preference) and sleep homeostasis in human studies. Pathway context only.
ADORA2A builds the adenosine receptor that caffeine blocks, and this variant has been associated with caffeine sensitivity and sleep traits. Pathway context only.
The dots after each gene are where your own result goes. Your report fills them in with the two letters you carry at that position.
Which of these variants do you carry?
Your report reads the DNA file you already have against this research.
Access
Access and legal status
DSIP is not an FDA-approved drug. Products sold online as “research chemicals” are labelled not for human use, and FDA treats them as unapproved drugs when they are marketed for people. We don't link to any seller, and nothing on this page is a recommendation to obtain or use it.
Your DNA and DSIP: see which of the variants studied alongside it you carry, and what that research does and does not show. Read my DNA, $99 →
Educational information only, not medical advice. Most peptides are not FDA-approved. Do not start, stop or change any medication or peptide because of this page; talk to a licensed clinician.
Worth knowing about DSIP
Interactions and situations where there is a specific reason to be careful. Where the honest answer is that nobody has studied something, it says so and says what that leaves open.
- The evidence is old and thin
- Most of the human work is decades old, small, and has not been repeated with modern sleep measurement. That is not a scandal, it is just the state of it.
- Persistent insomnia needs a diagnosis
- Sleep apnoea and other treatable causes look like ordinary bad sleep.
Last updated
Frequently Asked Questions
What has DSIP been studied for?
Deep sleep, first in preclinical work in the 1970s and then in small human studies in the 1980s, including in insomnia, with mixed results. It has not been tested with modern sleep measurement, and its mechanism is unresolved.
Do genes affect DSIP response?
No study has tested whether any genotype changes response to DSIP. ADA, PER3 and ADORA2A variants have been associated with sleep traits in human studies. A DNA report can show which versions you carry and what that research does and does not show.
Is DSIP legal?
DSIP is not approved as a medicine by any major regulator, and its human data are old and limited.
Watch
What clinicians and researchers say about DSIP
1 hr 30 minPeptide Expert: What Do Peptides Actually Do? (EXPLAINED) - Dr Alex TatemThe Diary of a CEO · PodcastBPC-157TB-500MOTS-c
19 minLearn Peptides So Fast it's UNREALAshley Froese · EducatorGHK-CuKPVThymosin Alpha-1
10 min11 Peptides Just Got Greenlit by the FDA (Here's What Changed)Ashley Froese · EducatorBPC-157TB-500KPVLearn more about DSIP
Your DNA and DSIP
What the research says about your variants.
The report
Which DSIP variants do you carry?
Your report reads the DNA file you already have against the published research on 31 peptides, marker by marker, and says what that research does and does not show.
Read my DNA, $99